Pricing patients out of healthcare?
Patients are being victimized by the high cost of drug therapy. "We can help them by prescribing less expensive drugs and by guiding them to the least expensive places to purchase them," says Dr. Norman Levine.
Image IQ: When is a biopsy required?
In this quiz, Kaivon Sobhani, B.S., and, Eve Lowenstein, M.D., Ph.D., FAAD, address dermatofibrosarcoma protuberans (DFSP), keloids, hypertrophic scars and dermatofibromas.
Rare tumors and fibrotic skin lesions
In this review article, Kaivon Sobhani, B.S., and, Eve Lowenstein, M.D., Ph.D., examine fibrotic skin lesions, including the cutaneous tumor dermatofibrosarcoma protuberan (DFSP).
New Drugs Roundup: Dermatology
The July issue of Dermatology Times highlights some newly approved treatments in dermatology including a new wrinkle filler and new treatment for seborrheic keratosis.
The top 7 mobile apps in dermatology
Only 20% of mobile dermatology apps designed for patients may be worthwhile, shows an analysis published in February in the online journal Cutis. Learn more in this slideshow.
Medicine no longer apolitical
Physicians writing in the Journal of the American Academy of Dermatology say that physicians should counter the proliferation of fake news on climate change.
Study: Novel 670 nm wavelength works for benign pigmented lesions
A novel picosecond/nanosecond 670 nm wavelength is safe and effective for the treatment of benign pigmented lesions.
I use social media and now I might lose my license?
Dr. Jam is a successful medical and cosmetic dermatologist who posted a video online intended as a promotional video. His patients are suing claiming negligence. Learn more here.
Complications low with chemical peels in darker skin
Superficial chemical peels have a relatively low complication rate in patients with darker skin types when performed appropriately, a study finds.
Non-physician operators target of most legal action for laser procedures
There is increasing patient injury and legal action from cutaneous laser surgery, particularly when performed by non-physicians.
Where full-field erbium outshines fractional
Despite the popularity of fractional ablative resurfacing, full-field erbium resurfacing still has an important role in skin rejuvenation.
eConsults support underserved patients
Study shows how primary care and dermatology practices can collaborate to serve underserved populations.
Considerations for diagnosing eosinophilic fasciitis
Eosinophilic fasciitis is a rare condition for which there are no established diagnostic criteria or clinical guidelines for its management.
Avoid antibiotics for acne treatment when possible
Years ago antibiotics were used to treat acne because it was thought that the condition was an infectious disease, says Dr. Hilary Baldwin of the Rutgers Robert Wood Johnson Medical School.
Is it acne or Pityrosporum folliculitis?
Review highlights the need to accurately diagnose this common bacterial infection.
Skin cancer expenditures creep higher
The cost of skin cancer treatments continue to increase in the United States where a large proportion of expenditures stem from the cost of systemic agents for melanoma.
Skin care for sensitive and diseased skin
The skin care industry promotes products designed for sensitive skin, yet dermatologists are concerned about the use of skin care products for skin disease.
Fewer follow-ups for localized melanoma
Some melanoma patients prefer fewer follow-up visits, but only if self-skin examinations were utilized at home or teledermatology implemented for a quick assessment.
More patients want digital health
The AMA’s chief information officer talks digital health technology with Dermatology Times.
Four questions every provider should ask about digital technology
There are four questions physicians should ask when considering using digital healthcare technologies, says Michael L. Hodgkins, M.D., chief medical officer for the American Medical Association. View the slideshow for more information.
Dosing schedules that optimize outcomes
Changing the schedule of targeted therapies has been shown to improve the response rate in a mouse model of melanoma.
Combination therapy improves survival in melanoma
The combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.
Immunotherapy still works post treatment in melanoma
Pembrolizumab has antitumor activity that is durable long after treatment is stopped in patients with advanced melanoma, researchers reported at the 2018 annual meeting of the American Society of Clinical Oncology (ASCO) on June 4.
The atopic march strides toward eosinophilic esophagitis
Eczema, food allergy, and asthma independently and cumulatively increase the risk for eosinophilic esophagitis (EoE), according to findings presented at the 2018 American Academy of Allergy, Asthma & Immunology and World Allergy Organization Joint Congress in Orlando.
Revised melanoma staging criteria
Staging system is derived from a new dataset of patients from 10 cancer centers around the world. Dermatologists should consider AJCC tumor characteristics as well as other factors in risk assessment, counseling, and follow-up plans for patients. Update takes effect in January 2018.
2 Clarke Drive Cranbury, NJ 08512